Merck & Co (MRK)

$73.08 0.23 (0.31%)

9:56 EST MRK Stock Quote Delayed 30 Minutes

Volume:

Previous Close -

Market Cap 196.60B

PE Ratio 126.00

EPS 0.58

Volume (Avg. Vol.) 1.92M

Day's Range 72.50 - 73.44

52-Week Range 65.25 - 87.80

Dividend & Yield 1.92 (2.63%)

MRK Stock Predictions, Articles, and Merck & Co News

From InvestorPlace
From the Web

What Will the Stock Market Do Today? 3 Big Stories to Watch.

By Sarah Smith, InvestorPlace Web Content Producer Mar 2, 2021

What will the stock market do today? Investors will focus on Warren's wealth tax, EV stocks and Covid-19 hopes. Here's what to know.

PAND Stock: Why Pandion Therapeutics Shares Have Skyrocketed Today

By William White, InvestorPlace Writer Feb 25, 2021

Pandion Therapeutics (PAND) stock is soaring higher on Thursday after announcing that Merck (MRK) plans to acquire the biotechnology company.

3 Under-the-Radar Biotech Stocks to Buy After Dull Earnings Reactions

By Nicolas Chahine, InvestorPlace Contributor Feb 8, 2021

Investors are enamored with high profile stocks and ignoring ones that are solid investments. Here are three biotech stocks to consider.

7 Pharmaceutical Stocks With Compelling Pipelines

By Chris Lau, InvestorPlace Contributor Feb 2, 2021

Covid-19 vaccines are getting all the glory after multi-bagger returns last year but these seven pharmaceutical stocks have a strong future ahead.

The 7 Best Healthcare Stocks to Buy for 2021

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Jan 20, 2021

Politics is a wildcard that can negatively impact healthcare stocks. But there are still many top companies with great prospects to consider.

6 Cannabis Stocks to Buy as the U.S. Softens Its Stance

By Lou Carlozo, InvestorPlace Contributor Dec 31, 2020

These 6 cannabis stocks show promise in the medical and recreational ends of the burgeoning marijuana sector, set to grow even more in 2021.

5 Rational Biotech Stocks to Buy

By Neil George, Editor, Profitable Investing Dec 22, 2020

These biotech stocks allow you to profit off the innovations that are giving us longer, healthier lives through the companies that make them.

The 7 Worst Dow Jones Stocks of 2020

By Tom Taulli, InvestorPlace Writer & IPO Playbook Editor Dec 22, 2020

The Dow Jones has gained about 5.5% this year, but not everything was so positive. These were the worst stocks in the Dow for 2020.

9 Best Stocks to Buy for the Santa Claus Rally

By Josh Enomoto, InvestorPlace Contributor Dec 4, 2020

With 2020 coming to a close, everyone’s talking about the best stocks to buy under the context of the Santa Claus rally. But just how effective is this methodology?

85 Million & Climbing: Why Pets = Profits for These 6 Companies

By Neil George, Editor, Profitable Investing Dec 3, 2020

More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.

Merck and Biotech’s Swashbuckling Era

By Dana Blankenhorn, InvestorPlace Contributor Nov 25, 2020

MRK stock has entered a new swashbuckling era, searching for new profit gushers like Keytruda, the company's anti-cancer drug.

9 Outbreak-Fueled Stocks to Buy This Week

By Josh Enomoto, InvestorPlace Contributor Nov 11, 2020

While coronavirus numbers start to subside again, many investors are in a pandemic mentality, making these the stocks to buy this week.

5 Industries Biden Would Destroy as President

By Thomas Niel Nov 2, 2020

If Joe Biden wins on Election Day, election stocks in these five industries could hit bad times: Coal, Cruise Lines, Oil and Gas, Pharmaceuticals, Ride Sharing. Tread carefully as voters head to the polls.

7 Value Stocks To Buy in an Overvalued Market

By Josh Enomoto, InvestorPlace Contributor Oct 15, 2020

While the coronavirus has brought excitement back to the markets, it’s the contrarian who is eyeballing value stocks that stands to win in the long run.

7 Highly Rated Pharmaceutical Stocks for Q4

By Joel Baglole Oct 12, 2020

Investors are banking on an upsurge in pharmaceutical stocks once various vaccines and other therapies gain commercial approval from the U.S. Food and Drug Administration (FDA). Here is a list of pharmaceutical companies that stand to benefit in the coming months.

Navellier Ratings

Total Grade

Sell

Merck & Co (MRK)

MRK Stock Predictions, Articles, and Merck & Co News

Navellier Ratings

Total Grade

Subscriber Sign in